An analysis of the alpha- and beta-effects of isoprenaline on the isolated nictitating membrane
Experiments with specific receptor antagonists and determinations of relative potencies of catecholamines indicated that contractile responses to isoprenaline were mediated by alpha-adrenoceptors and relaxant effects by beta-adrenoceptors.
In the absence of any receptor antagonists the alpha-effects of isoprenaline interfere with measurements of the beta-effects (and vice versa). Hence, pD2-values and intrinsic activities determined for the beta-effects of isoprenaline in the absence of phentolamine must be regarded as apparent values.
For an agent which potentiates the beta-effects of isoprenaline without affecting its alpha-effects (e.g., hydrocortisone), the apparent degree of super-sensitivity to the beta-effects (determined in the absence of phentolamine) is an underestimate of the true degree of supersensitivity.
The magnitude of the relaxant response to a given concentration of isoprenaline was greatest for half-contracted muscles and very small for fully contracted or fully relaxed muscles. The apparent pD2 for the beta-effects of isoprenaline was negatively correlated with the height of steady-state contraction existing prior to the administration of isoprenaline. This correlation was largely independent of the agonist used to elicit the contraction. Hence, the state of the contractile system determines the response to isoprenaline.
The relaxant effect of theopyhylline also depended on the state of the contractile system. Theophylline failed to potentiate the beta-effects of isoprenaline.
The present results largely verify the validity of earlier measurements of the pD2 for the alpha- and beta-effects of isoprenaline.
Key wordsIsoprenaline Nictitating Membrane Relaxation of Smooth Muscle Supersensitivity Theophylline
Unable to display preview. Download preview PDF.
- Blinks, J. R.: The nature of the antagonism by methoxamine of the chronotropic and iontropic effects of catecholamines. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 248, 73–84 (1964)Google Scholar
- Burn, J. H.: Practical Pharmacology. Oxford: Blackwell 1952Google Scholar
- Giles, R. E., Miller, J. W.: Studies on the potentiation of the inotropic actions of certain catecholamines by U-0521 (3′,4′-dihydroxy-alpha-methyl propiophenone). J. Pharmacol. exp. Ther. 157, 55–61 (1967)Google Scholar
- Graefe, K.-H., Trendelenburg, U.: The effect of hydrocortisone on the sensitivity of the isolated nictitating membrane to catecholamines: relationship to extraneuronal uptake and metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 1–48 (1974)Google Scholar
- Guimaraes, S., Osswald, W.: Adrenergic receptors in the veins of the dog. Europ. J. Pharmacol. 5, 133–140 (1969)Google Scholar
- Hertting, G.: The fate of 3H-isoproterenol in the rat. Biochem. Pharmacol. 13, 1119–1128 (1964)Google Scholar
- Pluchino, S., Trendelenburg, U.: The influence of denervation and of decentralization on the alpha and beta effects of isoproterenol on the nictitating membrane of the pithed cat. J. Pharmacol. exp. Ther. 163, 257–265 (1968)Google Scholar
- Schümann, H. J., Endoh, M., Wagner, J.: Positive inotropic effects of phenyl-ephrine in the isolated rabbit papillary muscle mediated by alpha- and beta-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 133–148 (1974)Google Scholar
- Smith, C. B.: Relaxation of the nictitating membrane of the spinal cat by sympathomimetic amines. J. Pharmacol. exp. Ther. 142, 163–170 (1963)Google Scholar
- Trendelenburg, U.: Factors influencing the concentration of catecholamines at the receptors. Handb. exp. Pharmakol., vol. XXXIII, pp. 726–761. Berlin-Heidelberg-New York: Springer 1972Google Scholar
- Trendelenburg, U., Draskóczy, P. R., Pluchino, S.: The density of adrenergic innervation of the cat's nictitating membrane as a factor influencing the sensitivity of the isolated preparation to l-norepinephrine. J. Pharmacol. exp. Ther. 166, 14–25 (1969)Google Scholar
- Trendelenburg, U., Höhn, D., Graefe, K.-H., Pluchino, S.: The influence of block of catechol-O-methyl transferase on the sensitivity of isolated organs to catecholamines. Naunyn-Schmiedebergs Arch. Pharmak. 271, 59–92 (1971)Google Scholar
- Van den Brink, F. G.: The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Europ. J. Pharmacol. 22, 270–278 (1973a)Google Scholar
- Van den Brink, F. G.: The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists. Europ. J. Pharmacol. 22, 279–286 (1973b)Google Scholar